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ABSTRACT 
 
Zinc-based glass polyalkenoate cements have been synthesised and their potential use 
in orthopaedic applications investigated. Zinc ions were released from the materials in 
a rapid burst over the first 24 h after synthesis, with the release rate falling below 
detectable levels after 7 days. Cement-implanted bone samples were prepared and the 
released zinc was shown, using energy dispersive X-ray analysis, to penetrate from 
the cement into the adjacent bone by up to 40 µm. Finally, the cements exhibited 
antibacterial activity against Streptococcus mutans and Actinomyces viscosus that 
reflected the pattern of zinc release, with the inhibition of growth greatest shortly after 
cement synthesis and little or no inhibition measureable after 30 days. 
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1.  Introduction 
Poly (methyl methacrylate) (PMMA) bone cement is currently the only material 
used for anchoring total joint replacements to the contiguous bone in cemented 
arthroplasties. However, PMMA can impair the correct functioning of the immune 
system, leading to a safe haven for the proliferation of contaminating bacteria around 
cemented prostheses [1] and thereby contributing to the 7% of hip revision surgeries 
caused by primary deep infection [2]. Glass polyalkenoate cements (GPCs), 
commonly used in dentistry, are recognised for their ability to prevent secondary 
caries through the release of antibacterial agents such as fluoride and strontium [3]. 
However, the presence of aluminium in the glass phase of commercially available 
GPCs has restricted their use in orthopaedics as aluminium is believed to cause 
defective bone mineralisation [4,5] and has been implicated in the pathogenesis of 
degenerative brain diseases such as Parkinson’s and Alzheimer’s disease [6-8]. 
Zinc oxide (ZnO) has the ability to act as both a network modifier and intermediate 
oxide in a similar method to alumina, and the authors have previously shown that 
aluminium-free GPCs can be produced based on calcium-zinc silicate glasses [9]. The 
properties and characteristics of the resultant cements are similar to their aluminium-
based counterparts and the replacement of aluminium with zinc makes these materials 
suitable for widespread orthopaedic applications. The novel zinc releasing bone 
cements examined in this study offer advantages over conventional acrylic bone 
cements. They are not based on a toxic monomer, they exhibit no significant 
exotherm [10] and in vitro work has indicated that they may bond directly to bone 
[11]. 
Zinc-containing materials such as zinc phosphate and zinc polycarboxylate 
cements have been utilised for a number of years in clinical dentistry, due to their 
ability to release ions that inhibit the growth of caries-related bacteria such as 
Streptococcus mutans and Actinomyces viscosus [12,13]. In addition to its 
antibacterial activities, zinc is important in healthy bone growth and development [14] 
and is required for effective functioning of the body’s immune system [15,16]. 
Furthermore, low bioavailability of zinc has been found to reduce resistance to 
infection in aging members of the population [17]. 
The aim of this study, therefore, was to highlight the potential of these zinc-based 
GPCs as alternative bone cements to PMMA, by establishing the extent of zinc 
release from them, evaluating the depth of penetration of these ions into surrounding 
bone in vitro and measuring the antibacterial properties of the released zinc. 
  
 
2.  Materials and Methods 
2.1.  Glass Compositions 
Two glass compositions were produced, as described in Table 1. Glass A contains 
calcium, zinc and silica, while in glass B the calcium was replaced by strontium. 
Appropriate amounts of analytical grade silica, zinc oxide and either calcium 
carbonate or strontium carbonate were weighed out in a plastic tub and mixed in a ball 
mill (1 h), followed by drying in a vacuum oven (100°C, 1 h). The pre-fired glass 
batch was transferred to a mullite crucible for firing (1580°C, 1 h). The glass melts 
were then shock quenched into demineralised water and the resulting frit was dried, 
ground and sieved. The glass that passed through a 45 µm sieve was used to produce 
the cements.  
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2.2.  Polyacrylic acid (PAA) 
PAA was supplied in aqueous solution (25% w/v) by Ciba speciality polymers 
(Bradford, UK). The acid was coded E7 and had an average molar mass (Mn) of 8,140 
[18]. The acid was freeze-dried, ground and sieved through a <90 µm filter.  
 
2.3.  Preparation of cement discs and extracts. 
Two cement formulations were prepared, A and B, based on glasses A and B, 
respectively. Each formulation used 1 g of the corresponding glass, 0.36 g of PAA 
and 0.55 ml of water, resulting in a P:L ratio of 1:0.91 for both cements. Split ring 
moulds were used to produce cement discs (n=3) with a thickness of 1 mm and an 
internal diameter of 5 mm. The cements were mixed on a clean glass slab with a 
stainless steel dental spatula. Thirty seconds after mixing the moulds were filled to 
excess with cement, covered with acetate and clamped between Perspex plates. The 
clamped samples were maintained at 37°C for 1 h after the start of mixing. Flash was 
subsequently removed by grinding samples in their moulds with 1200 grit silicon 
carbide paper. Samples were de-moulded, washed with ethanol and stored in 10 ml 
aliquots of distilled water. Cement discs were removed from the water after 30 min, 1 
h, 2 h, 4 h, 24 h, 7 days and 30 days. The zinc concentration of the extracts was 
measured using a Varian SpectrAA-400 Atomic Absorption Spectrometer, with a 
lamp-current of 5mA in an air/acetylene flame with wavelength 213.9 nm. Standard 
solutions of 0.5 ppm, 1.0 ppm, 1.5 ppm and 2.0 ppm were used to calibrate the system 
prior to use and three measurements were taken from each aliquot in order to 
determine the mean concentration of zinc at each time interval. 
 
2.4.  Preparation of cement implanted bone sample 
A piece of bovine femur (5 cm x 5 cm x 2.5 cm) was cleaned and a hole (5 mm ∅) 
was drilled through the center of the bone, followed by thorough washing with 
distilled water. Cement A was mixed as described previously and used to fill the hole 
in the bone to excess. This was covered at either end with acetate sheets, clamped 
between two steel plates and allowed to set for 1 h at 37°C. The construct was then 
removed from the clamp and each surface polished gently using 1200 grit silicon 
carbide paper. The construct was stored in distilled water for 30 days, following 
which it was removed, dried and lightly polished. 
 
2.5.  Scanning electron microscopy and energy dispersive X-ray analysis 
A JOEL JSM-840 scanning electron microscope (SEM) equipped with a Princeton 
Gamma Tech (PGT) energy dispersive X-ray (EDX) system was used to obtain 
secondary electron images and to carry out chemical analysis of the bone-cement 
interface. EDX measurements were performed across the bone-cement interface in 
order to examine the extent of ion migration into the bone. Sites at which zinc and 
calcium measurements were taken are illustrated in Figure 1 and ranged from 60 µm 
on the bone side of the bone-cement inteface (Figure, point 1), through the interface, 
to 60 µm into the cement (Figure 1, point 7), with samples taken 20 µm distances 
apart. All EDX spectra were collected at 20 kV, using a beam current of 0.26 nA. 
Quantitative EDX converted the collected spectra into concentration data by using 
standard reference spectra obtained from pure elements under similar operating 
parameters, according to standard procedures. 
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2.6.  Agar disc-diffusion test 
The antibacterial activity of the cements was evaluated against the oral bacterial 
species S. mutans (American Type Culture Collection, ATCC, 25175) and A. viscosus 
(ATCC 19246), using the agar disc-diffusion method [3]. The bacteria were grown 
from stock cultures on brain heart infusion (BHI) agar at 37°C for 16 h and isolated 
colonies were used to seed fresh cultures in 10 ml Luria Broth (LB). After incubation 
at 37°C for 12-16 h with shaking (200 rpm), the cultures were diluted in Mueller 
Hinton (MH) broth to give an OD600 of 0.05 for S. mutans and 0.1 for A. viscosus. A 
350-µl volume of each bacterial suspension was streaked using clinical swabs on MH 
agar plates containing agar of 4 mm height, following which 2-3 discs of each 
material were placed on the agar. The plates were inverted and incubated under 
aerobic conditions (36 h, 37°C). Callipers were used to measure zones of inhibition at 
three different diameters for each disc and zone sizes were calculated as follows:  
Size of inhibition zone (mm) = (halo ∅ - disc ∅) / 2. 
All cements were analysed in triplicate and mean zone sizes ± standard deviations 
were calculated. 
 
 
3.  Results and Discussion 
3.1.  Zinc release measurements 
Cumulative zinc release from each cement was measured at intervals up to 30 days as 
outlined in section 2.3. In both cements the rate of zinc release was seen to decrease 
with respect to time, with the highest release rates measured immediately after 
production and no detectable zinc being released after 7 days (Figure 2). The absolute 
levels of zinc released were lower in the case of cement B than cement A, even 
though the glasses used as the base for the two cements contain identical amounts of 
zinc (Table 1). There is no obvious reason why this should be the case but it is 
possible that the replacement of calcium with strontium in glass B results in a more 
integral network, thereby inhibiting the release of zinc. Further investigation of the 
glass structure and the mechanical properties of the cements would be necessary to 
confirm this. 
The observed pattern of a sudden zinc release concurs with other published studies: 
Osinaga and co-workers [13] reported that the highest zinc release was detected in 
their zinc-added glass ionomer-based cements within 24 h of preparation and that zinc 
release was completed within the 15 day period of the study. Meanwhile, Foley and 
Blackwell [12] have reported the highest rate of zinc release from zinc-containing 
cements to occur after 2 days – the shortest incubation period investigated in their 
analysis – and a zinc release rate of "effectively zero" after 28 days. 
 
3.2. Investigation of bone-cement interface 
SEM and EDX were used to study the interface of the GPC implanted into bone and 
to generate calcium and zinc profiles across the interface. Control EDX data were 
measured for bone 2 cm from the bone-cement interface and at the centre of the 
implant for the cement. The EDX data indicated significant migration of zinc into the 
bone from a depth of 20-40 µm in the cement. This migration increased the normal 
zinc content in the bone from 3.1 wt %, as determined in the bone control sample, to 
14.8 wt % 60 µm away from the cement interface in the bone. Given that zinc ions 
have been shown to have significant antibacterial effects in vivo and in vitro, this 
increased concentration of zinc ions in the cement-contiguous bone, and at the bone-
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cement interface in particular, may have important implications for the inhibition of 
growth of contaminating bacteria in prosthetic joints. 
 
3.3.  Antibacterial activity of cements 
Inhibition of bacterial growth showed a clear correlation with released zinc, as zones 
of growth inhibition were largest with freshly prepared cements and became smaller 
as incubation times increased (Figures 4 and 5). This trend was observed with both 
cements and with both bacterial species tested. It correlates well with the atomic 
absorption results which indicate that the leachable zinc was lost rapidly to the storage 
solution (Figure 2), so that by 7 days most of the leachable zinc had been lost from the 
cement sample and was unavailable for release into the agar plate. Accordingly, after 
30 days’ incubation in distilled water, zones of inhibition were not significantly above 
zero in 3 of the 4 cement-bacterial combinations tested (Figures 4 and 5), indicating 
that the antibacterial effects of the samples had all but disappeared. Other researchers 
have also reported the greatest inhibition of S. mutans growth to be associated with an 
initial high level of ion release from zinc-containing cements, followed by reduced 
antibacterial activity over time due to significantly lower ion release levels [14]. In 
one such study, inhibition of S. mutans growth was detectable only with 1 h aged 
cements and no inhibition was detectable in materials that had been aged for 15 days, 
though no measurements were taken in the intervening time as in this work [15]. 
The antibacterial activity measured with cement A was greater than that of cement 
B, which correlated with the higher zinc release rates observed with the former 
(Figure 2). The strontium included in cement B was not found to increase the 
antibacterial effects of the cements, even though it has previously been shown to be 
inhibitory to bacterial growth when incorporated into similar materials [3]. In the 
previous published analysis, however, strontium concentrations were considerably 
higher than those investigated in this work, which may account for the discrepancy. 
There was no significant difference between the inhibitory effects of the cements 
on S. mutans and A. viscosus. Such comparisons between different cultures are 
difficult to make, however, as agar diffusion assays are extremely sensitive to the 
density and growth phase of the individual cultures at the time of harvesting. 
Nevertheless, the two cements exhibited significant inhibition of both bacterial 
species. 
Numerous studies have outlined the complications associated with bacterial 
infection after total hip arthroplasty (THA) [19,20]. The bacteria most commonly 
found in infected hip joints are Streptococci and Staphylococci [21,22], though 
members of numerous other genera such as Actinomyces [23,24], including 
Actinomyces viscosus [25], Prevotella [26] and Pseudomonas [27] have also been 
reported. Thus, the two bacteria analysed in this study, as well as being common 
caries-associated species, were selected as representative of the many bacterial 
species isolated from infected hip joints. In addition, there is a recognised link 
between caries-causing microorganisms and bacterial infection of prosthetic hip 
joints, with a number of studies reporting THA infections that were preceded by 
dental work and associated with bacteria that are normally found exclusively in the 
mouth [28-31]. The growth inhibitory effects observed with S. mutans and A. viscosus 
in this work are therefore clearly of relevance to prevention of THA infections in a 
clinical setting. 
Bacterial infections of prosthetic hip joints have a considerable financial 
consequence, both for the patient and the healthcare provider, and can necessitate 
extended antibiotic treatment and numerous surgical interventions, as well as causing 
 7
long-term physical and mental hardship for the patient. In an attempt to avoid such 
infections, antibiotic-impregnated cement spacers have been utilised in THA in order 
to achieve localised, extremely high concentrations of antibiotics that minimise 
bacterial growth [20,31]. Problems associated with such antibiotic-impregnated 
cements, however, include weakening of the cement itself and the generation of 
antibiotic-resistant bacteria in infected implant sites [31]. 
As zinc inhibits multiple activities in the bacterial cell, such as glycolysis, 
transmembrane proton translocation and acid tolerance [14], it has been shown to 
exhibit an antibacterial effect at considerably lower concentrations than many 
antimicrobial agents [32]. Furthermore, though generally regarded as bacteriostatic, it 
can have bactericidal effects also, particularly when used in combination with other 
ions, such as fluoride [33], or antibacterial agents [34]. Therefore, the use of zinc-
containing cements such as those investigated here might permit incorporation of 
antibiotics at considerably lower concentrations than are currently necessary to avoid 
bacterial infections in THA. This would not only reduce sample weakening but, due 
to the simultaneous presence of the two antibacterial agents, might be expected to 
reduce the rate at which antibiotic resistant bacteria arise. 
 
 
4.  Conclusions 
Bacterial infection after THA is a serious complication of hip replacement surgery 
that frequently necessitates revision surgeries. In this work, we have synthesised and 
characterised zinc-containing glass polyalkenoate cements to investigate their 
potential use in THA. Zinc was released from the study cements in a rapid burst after 
synthesis and released zinc ions could penetrate into contiguous bone by up to 40 µm. 
The growth of two characteristic bacterial species, Streptococcus mutans and 
Actinomyces viscosus, was significantly inhibited by the released zinc in in vitro 
studies, while maximal zinc release rates corresponded with the greatest inhibition of 
the two bacteria. We suggest that such zinc-containing materials may have potential 
in hip replacement surgery due to this inhibitory activity and may be particularly 
effective if used in conjunction with impregnated antibiotics. This dual selective 
pressure would allow the use of lower concentrations of antibiotics, thus reducing 
cement weakening associated with antibiotic impregnation, and would reduce the 
frequency with which resistant bacteria colonise such joints. 
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Table 1:  Glass formulations expressed as mole fractions 
 
Glass CaO SrO SiO2 ZnO 
A 0.05 0 0.42 0.53 
B 0 0.05 0.42 0.53 
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Figure Legends: 
 
Figure 1  Secondary electron microscope image of the bone-cement interface. Points 
for quantitative EDX are labelled 1-7 (spaced 20 µm apart). Control EDX data for 
bone was measured 2 cm from interface and at the centre of the cement implant for 
cement. 
 
 
Figure 2  Cumulative zinc release from cements A and B up to 30 days after 
synthesis. 
 
 
Figure 3  Normal weight % EDX data for calcium and zinc content across the 
interface of GPC implanted into bovine bone. EDX points are illustrated in Figure 1. 
Control values are included. 
 
 
Figure 4  Inhibition of growth of A. viscosus. 
 
 
Figure 5  Inhibition of growth of S. mutans. 
 
 
 
